KIT and mast cell neoplasm: For instance, the oncogenic KIT mutations, such as KIT D816V and KIT V560G, lead to constitutively active tyrosine kinase activity and growth factor-independent proliferation of mast cells in tissue lesions associated with mast cell tumors and systemic mastocytosis37,38.